Cancer Conversations™ in RCC: Improving Outcomes With Immunotherapy and Targeted Agents

Improve your knowledge and apply expert insights on current treatment options for RCC from selecting first-line therapy through understanding treatment options after multiple lines of treatment. View a discussion by experts in an on-demand webcast from a live webinar and then download the slides for use in your own presentations.

Share

Program Content

No activities added yet

No activities added yet

Provided by

ProCE Banner

Supporters

Supported by educational grants from

Eisai

Exelixis, Inc.

Merck Sharp & Dohme Corp.